Rectal/Anal clinical trials at University of California Health

1 research study open to eligible people

CG-100 Intraluminal Bypass Device
open to eligible people ages 22-70
A randomized trial to assess the safety and efficacy of CG-100 for reducing stoma creation rate in subjects undergoing mesorectal excision.
at UC Irvine

Last updated: October 20, 2025